Skip to content
  • Sunday, 26 July 2026
  • 4:29 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Researchers Uncover Dual-Ligase Mechanism for Targeted Protein Degradation, Paving Way for More Robust and Durable Cancer Therapies
Biotech & Genetic Research

Researchers Uncover Dual-Ligase Mechanism for Targeted Protein Degradation, Paving Way for More Robust and Durable Cancer Therapies

Jia Lissa May 13, 2026 0

A groundbreaking study has identified a novel mechanism by which a single small molecule can leverage two distinct cellular pathways…

Read More
Pharmaceutical R&D

Gilead Sciences Reports Robust Q1 2026 Performance Driven by Strong HIV Portfolio and Promising PrEP Launches

Teuku Ryan May 9, 2026 0

Gilead Sciences has commenced 2026 with a demonstrably strong first quarter, reporting significant revenue growth primarily fueled by its leading…

Read More
Data Science & Bioinformatics

Building Modern EDA Pipelines with Pingouin: Enhancing Data Quality for Robust Machine Learning Models

Evan Lee Salim May 8, 2026 0

The adage "garbage in, garbage out" (GIGO) stands as an undisputed truth in the realm of machine learning, underscoring the…

Read More
Data Science & Bioinformatics

Elevating SQL Development: Integrating Software Engineering Principles for Robust Data Solutions

Evan Lee Salim May 4, 2026 0

The landscape of data engineering and analytics has evolved dramatically, moving from ad-hoc querying to complex, mission-critical data pipelines that…

Read More
Data Science & Bioinformatics

The ‘Robust’ Data Scientist: Winning with Messy Data and Pingouin

Evan Lee Salim May 1, 2026 0

In the dynamic and often unpredictable landscape of real-world data science, the idealized conditions presented in academic textbooks frequently diverge…

Read More
Pharmaceutical R&D

Novartis Navigates Generics Storm in Q1, Eyes Robust Future Fueled by Strategic Acquisitions and Pipeline Advancements

Teuku Ryan Apr 30, 2026 0

Novartis reported a challenging first quarter for 2026, with profits experiencing a significant downturn primarily due to the intensified impact…

Read More
Pharmaceutical R&D

Johnson & Johnson Forecasts Accelerated Growth in 2026 Driven by New Psoriasis Treatment, Icotyde, and Robust Pharma Portfolio

Teuku Ryan Apr 16, 2026 0

Johnson & Johnson (J&J) has reported a strong start to 2026, exceeding analyst expectations with robust first-quarter earnings and revising…

Read More
Data Science & Bioinformatics

Mastering Robust Error Handling: Five Essential Python Functions for Enhanced Software Resilience

Evan Lee Salim Mar 25, 2026 0

The digital landscape’s increasing complexity mandates sophisticated error handling strategies, moving beyond rudimentary try-except blocks to embrace proactive and preventative…

Read More
Pharmaceutical R&D

Earendil Labs Secures $787 Million to Accelerate AI-Driven Drug Discovery and Expand Robust Pipeline

Teuku Ryan Mar 23, 2026 0

Earendil Labs, a burgeoning biotechnology firm at the forefront of artificial intelligence (AI)-powered drug discovery, has announced a significant financial…

Read More
Data Science & Bioinformatics

Five Powerful Python Decorators for Building Robust AI Agents in Production Environments

Evan Lee Salim Mar 20, 2026 0

The transition of AI agents from controlled development environments to demanding production systems frequently uncovers a litany of vulnerabilities, leading…

Read More

Posts pagination

1 2
How CTF is trying to rescue pharma’s shelved rare disease drugsUniversity of Georgia Researchers Uncover and Define Two Previously Unknown Species of Black BassGinkgo Bioworks CEO Jason Kelly Discusses Autonomous Labs and the Future of Biopharma R&DPlasma Rotation Identified as Critical Factor in Fusion Reactor Particle Distribution and Divertor Efficiency
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ